GDC-0084
CAS No. 1382979-44-3
GDC-0084 ( RG-7666 )
Catalog No. M11585 CAS No. 1382979-44-3
A potent, selective, brain penetrant dual inhibitor of class I PI3Ks and mTOR with Ki of 2/46/3/10/70 nM for PI3Kα/β/δ/γ/mTOR, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 60 | In Stock |
|
5MG | 111 | In Stock |
|
10MG | 178 | In Stock |
|
25MG | 365 | In Stock |
|
50MG | 475 | In Stock |
|
100MG | 687 | In Stock |
|
500MG | 1431 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGDC-0084
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, brain penetrant dual inhibitor of class I PI3Ks and mTOR with Ki of 2/46/3/10/70 nM for PI3Kα/β/δ/γ/mTOR, respectively.
-
DescriptionA potent, selective, brain penetrant dual inhibitor of class I PI3Ks and mTOR with Ki of 2/46/3/10/70 nM for PI3Kα/β/δ/γ/mTOR, respectively; highly selective against a panel of 229 kinases (IC50>1 uM); shows antiproliferative (EC50 =0.3-1.1 uM) in 5 GBM cell lines; significantly and dose-dependently inhibits tumor growth in a subcutaneous U87 tumor xenograft model of glioblastoma in mice.Brain Cancer Phase 2 Discontinued
-
SynonymsRG-7666
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptormTOR;PI3Kα;PI3Kβ;PI3Kγ;PI3Kδ
-
Research AreaCancer
-
IndicationBrain Cancer
Chemical Information
-
CAS Number1382979-44-3
-
Formula Weight382.42
-
Molecular FormulaC18H22N8O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 6 mg/mL (Need ultrasonic)
-
SMILESNC1=NC=C(C2=NC(N3CCOCC3)=C4N=C(C(C)(C)OCC5)N5C4=N2)C=N1
-
Chemical Name2-Pyrimidinamine, 5-[8,9-dihydro-6,6-dimethyl-4-(4-morpholinyl)-6H-[1,4]oxazino[4,3-e]purin-2-yl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Heffron TP, et al. ACS Med Chem Lett. 2016 Feb 16;7(4):351-6.
2. Salphati L, et al. Drug Metab Dispos. 2016 Dec;44(12):1881-1889.
2. Salphati L, et al. Drug Metab Dispos. 2016 Dec;44(12):1881-1889.
molnova catalog
related products
-
MOMIPP
MOMIPP is a PIKfyve inhibitor and a macropinocytosis inducer. MOMIPP readily penetrates the blood-brain barrier and is moderately effective in suppressing progression of intracerebral glioblastoma xenografts.
-
Umbralisib
Umbralisib (RP5264,TGR1202, TGR-1202) is a potent, selective, orally available PI3Kδ inhibitor with IC50 of 22 nM.
-
Zandelisib
Zandelisib is an inhibitor of phosphatidylinositol 3-kinase (PI3K)(p110δ, IC50 of 3.5 nM), and with antineoplastic activity.